Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9979)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2017 (publication date) through Jan 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol 2017; 23(11): 2060-2067 [PMID: 28373773 DOI: 10.3748/wjg.v23.i11.2060] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i11/2060.htm |
| Number | Citing Articles |
| 1 |
Hiroki Teragawa, Chikage Oshita, Tomohiro Ueda. History of gastroesophageal reflux disease in patients with suspected coronary artery disease. Heart and Vessels 2019; 34(10): 1631 doi: 10.1007/s00380-019-01413-1
|
| 2 |
Yuta Yokoya, Ataru Igarashi, Akihito Uda, Hisato Deguchi, Toshihisa Takeuchi, Kazuhide Higuchi. Cost-utility analysis of a ‘vonoprazan-first’ strategy versus ‘esomeprazole- or rabeprazole-first’ strategy in GERD. Journal of Gastroenterology 2019; 54(12): 1083 doi: 10.1007/s00535-019-01609-2
|
| 3 |
A. V. Paraskevova, A. S. Trukhmanov, O. A. Storonova, S. V. Lyamina, S. V. Kalish, S. S. Pirogov, A. B. Ponomarev, D. E. Rumyantseva, I. Yu. Malyshev, I. V. Maev, V. T. Ivashkin. Macrophage phenotype after human refluxate exposure, esophageal dysmotility and their correlation with gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(1): 24 doi: 10.22416/1382-4376-2022-32-1-24-33
|
| 4 |
V. V. Gorban, I. V. Kovrigina, E. V. Gorban, E. S. Kameneva, O. V. Svistun. Syntropy of bronchial asthma and gastroesophageal reflux disease: pathogenetic features and possibilities of minimally invasive diagnostics at the outpatient stage. South Russian Journal of Therapeutic Practice 2023; 4(2): 25 doi: 10.21886/2712-8156-2023-4-2-25-34
|
| 5 |
Wen Juan Fan, Yuan Tao Hou, Xiao Hong Sun, Xiao Qing Li, Zhi Feng Wang, Meng Guo, Li Ming Zhu, Ning Wang, Kang Yu, Jing Nan Li, Mei Yun Ke, Xiu Cai Fang. Effect of high‐fat, standard, and functional food meals on esophageal and gastric pH in patients with gastroesophageal reflux disease and healthy subjects. Journal of Digestive Diseases 2018; 19(11): 664 doi: 10.1111/1751-2980.12676
|
| 6 |
Jerome R. Lechien, Jacqueline Allen, Francois Mouawad, Tareck Ayad, Maria Rosaria Barillari, Kathy Huet, Lise Crevier‐Buchman, Stéphane Hans, Petros D. Karkos, Young‐Gyu Eun, Francois Bobin, Sven Saussez, Lee M. Akst. Do Laryngologists and General Otolaryngologists Manage Laryngopharyngeal Reflux Differently?. The Laryngoscope 2020; 130(10) doi: 10.1002/lary.28484
|
| 7 |
Kosuke Sakitani, Nobumi Suzuki, Sozaburo Ihara, Yoshihiro Hirata, Shoji Kawazu, Yasuhiko Iwamoto, Kazuhiko Koike, Roberto Coppola. Decline in perception of acid regurgitation symptoms from gastroesophageal reflux disease in diabetes mellitus patients. PLOS ONE 2018; 13(3): e0194466 doi: 10.1371/journal.pone.0194466
|
| 8 |
Anna A. Shilova, Zajnab G. Alieva, Ol’ga A. Bashkina, Bela I. Kantemirova. Proton pump inhibitors in pediatric practice. Pediatric pharmacology 2023; 20(5): 490 doi: 10.15690/pf.v20i5.2606
|
| 9 |
O. D. Lopina, B. K. Nurgalieva, T. L. Lapina. Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(4): 55 doi: 10.22416/1382-4376-2021-31-4-55-63
|
| 10 |
Frank Zerbib, Albert J. Bredenoord, Ronnie Fass, Peter J. Kahrilas, Sabine Roman, Edoardo Savarino, Daniel Sifrim, Michael Vaezi, Rena Yadlapati, C.Prakash Gyawali. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease. Neurogastroenterology & Motility 2021; 33(4) doi: 10.1111/nmo.14075
|
| 11 |
Nan Zhang, Ming Han, Qin-Wei Zheng, Meng-Yuan Zhang, Wen-Lan Zhi, Jing-Jing Li, Lin-Xuan Cui, Jin-Li Tian, Yi Wang, Sheng-Quan Fang. A scientometrics analysis and visualization of refractory gastroesophageal reflux disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1393526
|
| 12 |
Azucena Arévalo-Galvis, William A. Otero-Regino, Gloria N. Ovalle-Celis, Eliana R. Rodríguez-Gómez, Alba A. Trespalacios-Rangel, Jed N. Lampe. Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PLOS ONE 2021; 16(1): e0245401 doi: 10.1371/journal.pone.0245401
|
| 13 |
Aiqing Zhang, Wenjuan Liu, Lingyun Niu, Liping Zhu, Liuqing Yang, Xueliang Li. Correlation analysis and prognostic value of miR-29a-3p expression and CYP2C19 genotypes in exfoliated cells from tongue coating of patients with gastroesophageal reflux disease. Genes & Genomics 2023; 45(5): 673 doi: 10.1007/s13258-022-01347-5
|